Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer M Ashraf-Uz-Zaman, S Shahi, R Akwii, MS Sajib, MJ Farshbaf, RR Kallem, ... European journal of medicinal chemistry 209, 112866, 2021 | 9 | 2021 |
Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis M Ashraf-Uz-Zaman, G Ji, D Tidwell, L Yin, S Thakolwiboon, J Pan, ... ACS chemical neuroscience 13 (2), 217-228, 2022 | 3 | 2022 |
Mechanistic Aspects of Biphenyl Urea-Based Analogues in Triple-Negative Breast Cancer Cell Lines R Bandy, S Shahi, N Quagraine, S Shahbazi Nia, MSI Howlader, ... ACS Pharmacology & Translational Science 7 (1), 120-136, 2023 | 1 | 2023 |
Characterization of a Nonselective Opioid Receptor Functional Antagonist: Implications for Development as a Novel Opioid Dependence Medication. YT Ortiz, ZG JD, L Shamir, K Frimpong-Manson, MA Hossain, S Shahi, ... ACS Pharmacology & Translational Science 7 (3), 654-666, 2024 | | 2024 |
Characterization of a Nonselective Opioid Receptor Functional Antagonist: Implications for Development as a Novel Opioid Dependence Medication S Shahbazi Nia, YT Ortiz, JD Zuarth Gonzalez, L Shamir, ... ACS Pharmacology & Translational Science, 2024 | | 2024 |
Correction to “Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis” M Ashraf-Uz-Zaman, G Ji, D Tidwell, L Yin, S Thakolwiboon, J Pan, ... ACS Chemical Neuroscience 13 (21), 3138-3138, 2022 | | 2022 |